Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Overexpression of small-conductance Ca2+-activated K+ channel 2 attenuates pain-like behavior in female mice with cystitis
Guadalupe Manrique-Maldonado, Xuejiao Sun, Allison L. Marciszyn, Nicolas Montalbetti, Marcelo D. Carattino
Guadalupe Manrique-Maldonado, Xuejiao Sun, Allison L. Marciszyn, Nicolas Montalbetti, Marcelo D. Carattino
View: Text | PDF
Research Article Nephrology Neuroscience

Overexpression of small-conductance Ca2+-activated K+ channel 2 attenuates pain-like behavior in female mice with cystitis

  • Text
  • PDF
Abstract

Small-conductance Ca2+-activated K+ (SK) channels regulate neuronal excitability and act as a feedback mechanism to limit firing during sustained stimulation. In the present study, we demonstrated that SK2 plays an important role in the control of bladder function and visceral pain processing. SK2 channels are expressed in bladder-innervating afferent neurons, and ablation of this subunit results in elevated afferent firing rates in response to physiological levels of bladder distension, supporting a role for SK2 in modulating mechanosensory excitability. Mice overexpressing SK2 exhibit increased bladder capacity and reduced voiding frequency. Furthermore, overexpression of SK2 prevents the onset of pelvic mechanical allodynia and attenuates the exaggerated visceromotor response to bladder distension seen in wild-type mice with chemical cystitis. Thus, SK2 may be a promising target for treating overactive bladder and pain originating from the urinary bladder and other pelvic organs.

Authors

Guadalupe Manrique-Maldonado, Xuejiao Sun, Allison L. Marciszyn, Nicolas Montalbetti, Marcelo D. Carattino

×

Figure 5

SK2 overexpression attenuates nociceptive responses in mice with chemical cystitis.

Options: View larger image (or click on image) Download as PowerPoint
SK2 overexpression attenuates nociceptive responses in mice with chemica...
(A) Experimental setup to assess the visceromotor response (VMR) to bladder distension. Saline is infused into the urinary bladder using a urethral catheter. Electromyography (EMG) activity is recorded with electrodes implanted in the oblique muscle and intravesical pressure with a transducer connected to the urethral catheter. (B and C) Representative EMG tracings during bladder distension for WT (B) and SK2+/T (C) mice treated with saline (SAL) and cyclophosphamide (CYP). Intravesical pressure is indicated on the left. SAL or CYP was administered every other day for a week. Bladder infusion initiation is denoted by a red arrow. (D) CYP administration potentiates the VMR response to bladder distension in WT mice (WT-SAL, n = 10; WT-CYP, n = 9; 2-way ANOVA, *P < 0.05). (E) SK2+/T mice are unaffected by CYP treatment (SK2+/T-SAL, n = 7; SK2+/T-CYP, n = 6). (F) Fifty percent withdrawal threshold grams to von Frey filaments applied to the pelvic area for WT and SK2+/T mice treated with SAL or CYP (WT-SAL, n = 10; WT-CYP, n = 10; SK2+/T-SAL, n = 11; SK2+/T-CYP, n = 11; ***P < 0.001, Kruskal-Wallis test followed by Dunn’s multiple-comparison test). Data are shown as the mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts